Company registration number 02894920 (England and Wales)
THESIS TECHNOLOGY PRODUCTS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
THESIS TECHNOLOGY PRODUCTS LIMITED
CONTENTS
Page
Accountants' report
1
Balance sheet
2
Notes to the financial statements
3 - 6
THESIS TECHNOLOGY PRODUCTS LIMITED
CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF THESIS TECHNOLOGY PRODUCTS LIMITED FOR THE YEAR ENDED 31 MARCH 2026
- 1 -
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Thesis Technology Products Limited for the year ended 31 March 2026 set out on pages 2 to 6 from the company’s accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.
This report is made solely to the board of directors of Thesis Technology Products Limited, as a body, in accordance with the terms of our engagement letter dated 10 October 2025. Our work has been undertaken solely to prepare for your approval the financial statements of Thesis Technology Products Limited and state those matters that we have agreed to state to the board of directors of Thesis Technology Products Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Thesis Technology Products Limited and its board of directors as a body, for our work or for this report.
It is your duty to ensure that Thesis Technology Products Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Thesis Technology Products Limited. You consider that Thesis Technology Products Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Thesis Technology Products Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Carpenter Box
21 September 2026
Chartered Accountants
Piper House
4 Dukes Court
Bognor Road
Chichester
West Sussex
PO19 8FX
THESIS TECHNOLOGY PRODUCTS LIMITED
BALANCE SHEET
AS AT 31 MARCH 2026
31 March 2026
- 2 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
3
502,667
510,921
Current assets
Stocks
351,690
330,578
Debtors
4
233,487
219,300
Cash at bank and in hand
490,853
507,316
1,076,030
1,057,194
Creditors: amounts falling due within one year
5
(330,403)
(347,020)
Net current assets
745,627
710,174
Net assets
1,248,294
1,221,095
Capital and reserves
Called up share capital
6
1,240
1,240
Capital redemption reserve
400
400
Profit and loss reserves
1,246,654
1,219,455
Total equity
1,248,294
1,221,095
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
For the financial year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 21 September 2026 and are signed on its behalf by:
Mr A J Thackray
Director
Company registration number 02894920 (England and Wales)
THESIS TECHNOLOGY PRODUCTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
- 3 -
1
Accounting policies
Company information
Thesis Technology Products Limited is a private company limited by shares incorporated in England and Wales. The registered office is Brooks Green Farm, Brooks Lane, Bosham, West Sussex, Chichester, PO18 8JX.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention.The principal accounting policies adopted are set out below.
1.2
Going concern
At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The directors have considered relevant information, including the company’s principal risks and uncertainties, the annual budget, forecast future cash flows and the impact of subsequent events in making their assessment. Based on these assessments and having regard to the resources available to the entity, the directors have concluded that there is no material uncertainty and that they can continue to adopt the going concern basis in preparing the annual report and financial statements.true
1.3
Turnover
Turnover is recognised at the fair value of the consideration receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
1.4
Research and development expenditure
Research expenditure is written off against profits in the year in which it is incurred.
1.5
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Land and buildings Freehold
2% straight line
Plant and machinery
8 years straight line
IT equipment
3 years straight line
Motor vehicles
5 years straight line
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
THESIS TECHNOLOGY PRODUCTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 4 -
1.6
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
1.7
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks.
1.8
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost.
Basic financial liabilities
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.9
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.10
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
1.11
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
1.12
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
THESIS TECHNOLOGY PRODUCTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 5 -
1.13
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was 36 (2025 - 37).
3
Tangible fixed assets
Land and buildings Freehold
Plant and machinery
IT equipment
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 April 2025 and 31 March 2026
603,254
31,688
18,056
27,213
680,211
Depreciation and impairment
At 1 April 2025
92,838
31,688
17,551
27,213
169,290
Depreciation charged in the year
7,749
505
8,254
At 31 March 2026
100,587
31,688
18,056
27,213
177,544
Carrying amount
At 31 March 2026
502,667
502,667
At 31 March 2025
510,416
505
510,921
4
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
204,213
192,463
Other debtors
29,274
26,837
233,487
219,300
THESIS TECHNOLOGY PRODUCTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 6 -
5
Creditors: amounts falling due within one year
2026
2025
£
£
Trade creditors
31,153
59,322
Taxation and social security
158,794
152,978
Other creditors
140,456
134,720
330,403
347,020
6
Called up share capital
2026
2025
2026
2025
Ordinary share capital
Number
Number
£
£
Authorised
Ordinary A shares of 10p each
5,000
5,000
500
500
Ordinary B shares of 10p each
5,000
5,000
500
500
Ordinary C shares of 10p each
1,002
1,002
100
100
Ordinary D shares of 1p each
30,000
30,000
300
300
41,002
41,002
1,400
1,400
Issued and fully paid
Ordinary A shares of 10p each
4,498
4,498
450
450
Ordinary B shares of 10p each
3,999
3,999
400
400
Ordinary C shares of 10p each
1,002
1,002
100
100
Ordinary D shares of 1p each
29,000
29,000
290
290
38,499
38,499
1,240
1,240
7
Directors' transactions
Dividends totalling £126,972.75 (2025 - £114,498) were paid in the year in respect of shares held by the company's directors.